1. Home
  2. ASMB vs KLXE Comparison

ASMB vs KLXE Comparison

Compare ASMB & KLXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • KLXE
  • Stock Information
  • Founded
  • ASMB 2005
  • KLXE 2018
  • Country
  • ASMB United States
  • KLXE United States
  • Employees
  • ASMB N/A
  • KLXE N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • KLXE Oilfield Services/Equipment
  • Sector
  • ASMB Health Care
  • KLXE Energy
  • Exchange
  • ASMB Nasdaq
  • KLXE Nasdaq
  • Market Cap
  • ASMB 84.5M
  • KLXE 83.1M
  • IPO Year
  • ASMB 2010
  • KLXE N/A
  • Fundamental
  • Price
  • ASMB $12.73
  • KLXE $4.68
  • Analyst Decision
  • ASMB Buy
  • KLXE Hold
  • Analyst Count
  • ASMB 2
  • KLXE 1
  • Target Price
  • ASMB $35.00
  • KLXE $4.50
  • AVG Volume (30 Days)
  • ASMB 23.6K
  • KLXE 153.5K
  • Earning Date
  • ASMB 03-27-2025
  • KLXE 03-05-2025
  • Dividend Yield
  • ASMB N/A
  • KLXE N/A
  • EPS Growth
  • ASMB N/A
  • KLXE N/A
  • EPS
  • ASMB N/A
  • KLXE N/A
  • Revenue
  • ASMB $28,326,000.00
  • KLXE $738,000,000.00
  • Revenue This Year
  • ASMB $282.16
  • KLXE N/A
  • Revenue Next Year
  • ASMB N/A
  • KLXE $4.79
  • P/E Ratio
  • ASMB N/A
  • KLXE N/A
  • Revenue Growth
  • ASMB N/A
  • KLXE N/A
  • 52 Week Low
  • ASMB $11.05
  • KLXE $4.18
  • 52 Week High
  • ASMB $19.93
  • KLXE $9.42
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 39.96
  • KLXE 38.60
  • Support Level
  • ASMB $12.10
  • KLXE $4.51
  • Resistance Level
  • ASMB $13.25
  • KLXE $4.92
  • Average True Range (ATR)
  • ASMB 0.60
  • KLXE 0.32
  • MACD
  • ASMB -0.07
  • KLXE -0.07
  • Stochastic Oscillator
  • ASMB 24.51
  • KLXE 12.88

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

Share on Social Networks: